Before the widespread use of the Hib vaccine,<unk>  accounted for 40%-60% of all meningitis cases in children under the age of fifteen, and 90% of all meningitis cases in children under the age of five. Vaccination can reduce incidence. Vaccination has reduced the occurrences of<unk>  by 87-90% in countries with widespread access to the Hib vaccine. Rates are still high in areas with limited levels of vaccination. Less-developed countries as well as countries with medical infrastructure that has been damaged in any way, such as from warfare, do not have such widespread access to the vaccine and thus experience higher rates of meningitis cases. Multiple conjugate Hib vaccines are available for use, though, and are extremely effective when given to infants. Additionally, the vaccine has only the side effects of reddened skin and swelling at the location of the injection.
Haemophilus meningitis
Herpesviral meningitis
Lemierre's syndrome
Eastern equine encephalitis
Fungal meningitis
Mollaret's meningitis
Tick-borne encephalitis
Diphtheria